Amy McMichael to Double-Blind Method
This is a "connection" page, showing publications Amy McMichael has written about Double-Blind Method.
Connection Strength
0.218
-
McMichael A, Desai SR, Qureshi A, Rastogi S, Alexis AF. Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials. Am J Clin Dermatol. 2019 Apr; 20(2):267-276.
Score: 0.150
-
Taylor SC, Cook-Bolden FE, McMichael A, Downie JB, Rodriguez DA, Alexis AF, Callender VD, Alvandi N. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype. J Drugs Dermatol. 2018 Feb 01; 17(2):160-167.
Score: 0.035
-
Strober BE, Menon K, McMichael A, Hordinsky M, Krueger G, Panko J, Siu K, Lustgarten JL, Ross EK, Shapiro J. Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study. Arch Dermatol. 2009 Nov; 145(11):1262-6.
Score: 0.020
-
Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N, McMichael A, Milbauer J, Phillips T, Powers J, Rodriguez D, Savin R, Shavin J, Sherer D, Silvis N, Weinstein R, Weiss J, Hammerberg C, Fisher GJ, Nighland M, Grossman R, Nyirady J. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol. 2005; 6(4):245-53.
Score: 0.014